Corrigendum to "FUTURE-2: Results from an open-label, long-term safety and tolerability extension study using the pediatric FormUlation of bosenTan in pUlmonary arterial hypeRtEnsion" [Int. J. Cardiol. 202 (2016) 52–58]. (15th November 2016) - Berger, Rolf M.F.; Haworth, Sheila G.; Bonnet, Damien; Dulac, Yves; Fraisse, Alain; Galiè, Nazzareno; Ivy, D. Dunbar; Jaïs, Xavier; Miera, Oliver; Rosenzweig, Erika B.; Efficace, Michela; Kusic-Pajic, Andjela; et al.